Listed

Aytu Biopharma, Inc

AYTUNasdaqCIK 1385818HealthcareFiscal year ends Jun 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$16.1m, Q4 FY2026
Operating income−$777.0k, Q4 FY2026
Net income−$15.0k, Q4 FY2026
Aytu Biopharma, Inc, income statement, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Revenue$m17.8Revenue, Q1 FY2024, three months to 2023-09-30$17.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure18.7Revenue, Q2 FY2024, three months to 2023-12-31$18.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure14.0Revenue, Q3 FY2024, three months to 2024-03-31$14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure14.6Revenue, Q4 FY2024, three months to 2024-06-30$14.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-09-23, accession 0001437749-25-029723. Derived: 12-month figure less the 9-month figure.Report this figure16.6Revenue, Q1 FY2025, three months to 2024-09-30$16.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure16.2Revenue, Q2 FY2025, three months to 2024-12-31$16.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure18.5Revenue, Q3 FY2025, three months to 2025-03-31$18.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure15.1Revenue, Q4 FY2025, three months to 2025-06-30$15.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure13.9Revenue, Q1 FY2026, three months to 2025-09-30$13.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure15.2Revenue, Q2 FY2026, three months to 2025-12-31$15.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure12.4Revenue, Q3 FY2026, three months to 2026-03-31$12.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure16.1Revenue, Q4 FY2026, three months to 2026-06-30$16.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure
Cost of revenue$m4.8Cost of revenue, Q1 FY2024, three months to 2023-09-30$4.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure4.1Cost of revenue, Q2 FY2024, three months to 2023-12-31$4.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure3.7Cost of revenue, Q3 FY2024, three months to 2024-03-31$3.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure3.5Cost of revenue, Q4 FY2024, three months to 2024-06-30$3.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-09-23, accession 0001437749-25-029723. Derived: 12-month figure less the 9-month figure.Report this figure4.6Cost of revenue, Q1 FY2025, three months to 2024-09-30$4.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure5.4Cost of revenue, Q2 FY2025, three months to 2024-12-31$5.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure5.6Cost of revenue, Q3 FY2025, three months to 2025-03-31$5.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure4.9Cost of revenue, Q4 FY2025, three months to 2025-06-30$4.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure4.7Cost of revenue, Q1 FY2026, three months to 2025-09-30$4.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure5.5Cost of revenue, Q2 FY2026, three months to 2025-12-31$5.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure4.8Cost of revenue, Q3 FY2026, three months to 2026-03-31$4.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure5.7Cost of revenue, Q4 FY2026, three months to 2026-06-30$5.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure
Gross profit$m13.0Gross profit, Q1 FY2024, three months to 2023-09-30$13.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure14.6Gross profit, Q2 FY2024, three months to 2023-12-31$14.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure10.4Gross profit, Q3 FY2024, three months to 2024-03-31$10.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure11.1Gross profit, Q4 FY2024, three months to 2024-06-30$11.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-09-23, accession 0001437749-25-029723. Derived: 12-month figure less the 9-month figure.Report this figure12.0Gross profit, Q1 FY2025, three months to 2024-09-30$12.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure10.8Gross profit, Q2 FY2025, three months to 2024-12-31$10.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure12.8Gross profit, Q3 FY2025, three months to 2025-03-31$12.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure10.3Gross profit, Q4 FY2025, three months to 2025-06-30$10.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure9.2Gross profit, Q1 FY2026, three months to 2025-09-30$9.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure9.6Gross profit, Q2 FY2026, three months to 2025-12-31$9.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure7.6Gross profit, Q3 FY2026, three months to 2026-03-31$7.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure10.4Gross profit, Q4 FY2026, three months to 2026-06-30$10.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure
Research and development$m0.6Research and development, Q1 FY2024, three months to 2023-09-30$595.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure0.5Research and development, Q2 FY2024, three months to 2023-12-31$521.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure0.6Research and development, Q3 FY2024, three months to 2024-03-31$611.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure1.0Research and development, Q4 FY2024, three months to 2024-06-30$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-09-23, accession 0001437749-25-029723. Derived: 12-month figure less the 9-month figure.Report this figure0.4Research and development, Q1 FY2025, three months to 2024-09-30$426.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure0.5Research and development, Q2 FY2025, three months to 2024-12-31$522.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure0.2Research and development, Q3 FY2025, three months to 2025-03-31$162.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure0.2Research and development, Q4 FY2025, three months to 2025-06-30$216.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure0.0Research and development, Q1 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure0.0Research and development, Q2 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure0.0Research and development, Q3 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure0.0Research and development, Q4 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(0.9)Operating income, Q1 FY2024, three months to 2023-09-30−$867.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure3.1Operating income, Q2 FY2024, three months to 2023-12-31$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure(1.6)Operating income, Q3 FY2024, three months to 2024-03-31−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure(2.3)Operating income, Q4 FY2024, three months to 2024-06-30−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-09-23, accession 0001437749-25-029723. Derived: 12-month figure less the 9-month figure.Report this figure(0.9)Operating income, Q1 FY2025, three months to 2024-09-30−$930.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure(1.7)Operating income, Q2 FY2025, three months to 2024-12-31−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure2.4Operating income, Q3 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure(7.6)Operating income, Q4 FY2025, three months to 2025-06-30−$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure(1.5)Operating income, Q1 FY2026, three months to 2025-09-30−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure(2.0)Operating income, Q2 FY2026, three months to 2025-12-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure(4.1)Operating income, Q3 FY2026, three months to 2026-03-31−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure(0.8)Operating income, Q4 FY2026, three months to 2026-06-30−$777.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure
Interest expense$m1.3Interest expense, Q1 FY2024, three months to 2023-09-30$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure1.3Interest expense, Q2 FY2024, three months to 2023-12-31$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure1.3Interest expense, Q3 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure1.3Interest expense, Q4 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-09-23, accession 0001437749-25-029723. Derived: 12-month figure less the 9-month figure.Report this figure1.0Interest expense, Q1 FY2025, three months to 2024-09-30$994.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure1.1Interest expense, Q2 FY2025, three months to 2024-12-31$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure0.9Interest expense, Q3 FY2025, three months to 2025-03-31$900.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure0.7Interest expense, Q4 FY2025, three months to 2025-06-30$730.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure0.5Interest expense, Q1 FY2026, three months to 2025-09-30$516.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure0.6Interest expense, Q2 FY2026, three months to 2025-12-31$560.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure0.4Interest expense, Q3 FY2026, three months to 2026-03-31$436.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure0.4Interest expense, Q4 FY2026, three months to 2026-06-30$383.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure
Income tax$m0.0Income tax, Q1 FY2024, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure0.8Income tax, Q2 FY2024, three months to 2023-12-31$780.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure0.5Income tax, Q3 FY2024, three months to 2024-03-31$521.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure0.8Income tax, Q4 FY2024, three months to 2024-06-30$841.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-09-23, accession 0001437749-25-029723. Derived: 12-month figure less the 9-month figure.Report this figure0.4Income tax, Q1 FY2025, three months to 2024-09-30$405.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure(0.3)Income tax, Q2 FY2025, three months to 2024-12-31−$283.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure(0.1)Income tax, Q3 FY2025, three months to 2025-03-31−$122.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure0.4Income tax, Q4 FY2025, three months to 2025-06-30$437.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure0.0Income tax, Q2 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure0.0Income tax, Q3 FY2026, three months to 2026-03-31$10.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure0.0Income tax, Q4 FY2026, three months to 2026-06-30$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure
Net income$m(8.1)Net income, Q1 FY2024, three months to 2023-09-30−$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure(0.2)Net income, Q2 FY2024, three months to 2023-12-31−$220.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure(2.9)Net income, Q3 FY2024, three months to 2024-03-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure(4.6)Net income, Q4 FY2024, three months to 2024-06-30−$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-09-23, accession 0001437749-25-029723. Derived: 12-month figure less the 9-month figure.Report this figure1.5Net income, Q1 FY2025, three months to 2024-09-30$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure0.8Net income, Q2 FY2025, three months to 2024-12-31$788.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure4.0Net income, Q3 FY2025, three months to 2025-03-31$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure(19.8)Net income, Q4 FY2025, three months to 2025-06-30−$19.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure2.0Net income, Q1 FY2026, three months to 2025-09-30$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure(10.6)Net income, Q2 FY2026, three months to 2025-12-31−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure(5.6)Net income, Q3 FY2026, three months to 2026-03-31−$5.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure(0.0)Net income, Q4 FY2026, three months to 2026-06-30−$15.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(1.48)Diluted EPS, Q1 FY2024, three months to 2023-09-30−$1.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure(0.04)Diluted EPS, Q2 FY2024, three months to 2023-12-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure(0.52)Diluted EPS, Q3 FY2024, three months to 2024-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figurenot reported(0.15)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure(0.26)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure0.21Diluted EPS, Q3 FY2025, three months to 2025-03-31$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figurenot reported(0.08)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure(1.05)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure(0.53)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figurenot reported
Basic EPS$ per share(1.48)Basic EPS, Q1 FY2024, three months to 2023-09-30−$1.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure(0.04)Basic EPS, Q2 FY2024, three months to 2023-12-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure(0.52)Basic EPS, Q3 FY2024, three months to 2024-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figurenot reported0.24Basic EPS, Q1 FY2025, three months to 2024-09-30$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure0.13Basic EPS, Q2 FY2025, three months to 2024-12-31$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure0.65Basic EPS, Q3 FY2025, three months to 2025-03-31$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figurenot reported0.21Basic EPS, Q1 FY2026, three months to 2025-09-30$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure(1.05)Basic EPS, Q2 FY2026, three months to 2025-12-31−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure(0.53)Basic EPS, Q3 FY2026, three months to 2026-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figurenot reported

Balance sheet

Cash and equivalents$26.3m, FY2026
Long-term debt$9.1m, FY2026
Shareholders' equity$35.3m, FY2026
Aytu Biopharma, Inc, balance sheet, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31FY20262026-06-30
Cash and equivalents$m20.0Cash and equivalents, Q1 FY2024, at 2023-09-30$20.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001558370-23-019015.Report this figure19.5Cash and equivalents, Q2 FY2024, at 2023-12-31$19.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-14, accession 0001437749-24-004149.Report this figure19.8Cash and equivalents, Q3 FY2024, at 2024-03-31$19.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001437749-24-017051.Report this figure20.0Cash and equivalents, FY2024, at 2024-06-30$20.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-09-23, accession 0001437749-25-029723.Report this figure20.1Cash and equivalents, Q1 FY2025, at 2024-09-30$20.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure20.4Cash and equivalents, Q2 FY2025, at 2024-12-31$20.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure18.2Cash and equivalents, Q3 FY2025, at 2025-03-31$18.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure31.0Cash and equivalents, FY2025, at 2025-06-30$31.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure32.6Cash and equivalents, Q1 FY2026, at 2025-09-30$32.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure30.0Cash and equivalents, Q2 FY2026, at 2025-12-31$30.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure26.7Cash and equivalents, Q3 FY2026, at 2026-03-31$26.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure26.3Cash and equivalents, FY2026, at 2026-06-30$26.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure
Current assets$m70.6Current assets, Q1 FY2024, at 2023-09-30$70.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019015.Report this figure71.4Current assets, Q2 FY2024, at 2023-12-31$71.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-14, accession 0001437749-24-004149.Report this figure71.1Current assets, Q3 FY2024, at 2024-03-31$71.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001437749-24-017051.Report this figure61.9Current assets, FY2024, at 2024-06-30$61.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-09-23, accession 0001437749-25-029723.Report this figurenot reportednot reported72.5Current assets, Q3 FY2025, at 2025-03-31$72.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure79.2Current assets, FY2025, at 2025-06-30$79.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure81.1Current assets, Q1 FY2026, at 2025-09-30$81.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure76.2Current assets, Q2 FY2026, at 2025-12-31$76.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure67.3Current assets, Q3 FY2026, at 2026-03-31$67.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure61.8Current assets, FY2026, at 2026-06-30$61.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure
Total assets$m133Total assets, Q1 FY2024, at 2023-09-30$132.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001558370-23-019015.Report this figure131Total assets, Q2 FY2024, at 2023-12-31$131.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-14, accession 0001437749-24-004149.Report this figure129Total assets, Q3 FY2024, at 2024-03-31$128.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001437749-24-017051.Report this figure118Total assets, FY2024, at 2024-06-30$118.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-09-23, accession 0001437749-25-029723.Report this figure116Total assets, Q1 FY2025, at 2024-09-30$115.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure116Total assets, Q2 FY2025, at 2024-12-31$116.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure124Total assets, Q3 FY2025, at 2025-03-31$124.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure124Total assets, FY2025, at 2025-06-30$124.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure125Total assets, Q1 FY2026, at 2025-09-30$125.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure122Total assets, Q2 FY2026, at 2025-12-31$122.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure112Total assets, Q3 FY2026, at 2026-03-31$111.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure105Total assets, FY2026, at 2026-06-30$105.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure
Current liabilities$m65.5Current liabilities, Q1 FY2024, at 2023-09-30$65.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-019015.Report this figure64.2Current liabilities, Q2 FY2024, at 2023-12-31$64.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-14, accession 0001437749-24-004149.Report this figure83.7Current liabilities, Q3 FY2024, at 2024-03-31$83.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001437749-24-017051.Report this figure62.2Current liabilities, FY2024, at 2024-06-30$62.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-09-23, accession 0001437749-25-029723.Report this figure61.3Current liabilities, Q1 FY2025, at 2024-09-30$61.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure64.0Current liabilities, Q2 FY2025, at 2024-12-31$64.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure70.7Current liabilities, Q3 FY2025, at 2025-03-31$70.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure63.1Current liabilities, FY2025, at 2025-06-30$63.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure66.0Current liabilities, Q1 FY2026, at 2025-09-30$66.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure65.6Current liabilities, Q2 FY2026, at 2025-12-31$65.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure60.0Current liabilities, Q3 FY2026, at 2026-03-31$60.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure54.7Current liabilities, FY2026, at 2026-06-30$54.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure
Total liabilities$m101Total liabilities, Q1 FY2024, at 2023-09-30$100.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001558370-23-019015.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Long-term debt$m15.0Long-term debt, Q1 FY2024, at 2023-09-30$15.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-14, accession 0001558370-23-019015.Report this figure15.0Long-term debt, Q2 FY2024, at 2023-12-31$15.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-02-14, accession 0001437749-24-004149.Report this figure0.0Long-term debt, Q3 FY2024, at 2024-03-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-15, accession 0001437749-24-017051.Report this figure10.9Long-term debt, FY2024, at 2024-06-30$10.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure10.4Long-term debt, Q1 FY2025, at 2024-09-30$10.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure10.0Long-term debt, Q2 FY2025, at 2024-12-31$10.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure9.5Long-term debt, Q3 FY2025, at 2025-03-31$9.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure10.9Long-term debt, FY2025, at 2025-06-30$10.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-09-23, accession 0001437749-25-029723.Report this figure10.4Long-term debt, Q1 FY2026, at 2025-09-30$10.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure10.0Long-term debt, Q2 FY2026, at 2025-12-31$10.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure9.5Long-term debt, Q3 FY2026, at 2026-03-31$9.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure9.1Long-term debt, FY2026, at 2026-06-30$9.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure
Current portion of debt$mnot reported0.0Current portion of debt, Q2 FY2024, at 2023-12-31$39.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-02-14, accession 0001437749-24-004149.Report this figure15.1Current portion of debt, Q3 FY2024, at 2024-03-31$15.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-15, accession 0001437749-24-017051.Report this figure1.9Current portion of debt, FY2024, at 2024-06-30$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure1.9Current portion of debt, Q1 FY2025, at 2024-09-30$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure1.9Current portion of debt, Q2 FY2025, at 2024-12-31$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure1.9Current portion of debt, Q3 FY2025, at 2025-03-31$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure1.9Current portion of debt, FY2025, at 2025-06-30$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-09-23, accession 0001437749-25-029723.Report this figure1.9Current portion of debt, Q1 FY2026, at 2025-09-30$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure1.9Current portion of debt, Q2 FY2026, at 2025-12-31$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure1.9Current portion of debt, Q3 FY2026, at 2026-03-31$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure1.9Current portion of debt, FY2026, at 2026-06-30$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure
Short-term borrowings$m1.2Short-term borrowings, Q1 FY2024, at 2023-09-30$1.2m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2023-11-14, accession 0001558370-23-019015.Report this figure1.0Short-term borrowings, Q2 FY2024, at 2023-12-31$1.0m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-02-14, accession 0001437749-24-004149.Report this figure1.6Short-term borrowings, Q3 FY2024, at 2024-03-31$1.6m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-05-15, accession 0001437749-24-017051.Report this figure2.4Short-term borrowings, FY2024, at 2024-06-30$2.4m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure4.3Short-term borrowings, Q1 FY2025, at 2024-09-30$4.3m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure4.0Short-term borrowings, Q2 FY2025, at 2024-12-31$4.0m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m32.2Shareholders' equity, Q1 FY2024, at 2023-09-30$32.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure32.9Shareholders' equity, Q2 FY2024, at 2023-12-31$32.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure30.8Shareholders' equity, Q3 FY2024, at 2024-03-31$30.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure27.7Shareholders' equity, FY2024, at 2024-06-30$27.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure29.8Shareholders' equity, Q1 FY2025, at 2024-09-30$29.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure30.8Shareholders' equity, Q2 FY2025, at 2024-12-31$30.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure34.9Shareholders' equity, Q3 FY2025, at 2025-03-31$34.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure19.0Shareholders' equity, FY2025, at 2025-06-30$19.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure23.2Shareholders' equity, Q1 FY2026, at 2025-09-30$23.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure14.2Shareholders' equity, Q2 FY2026, at 2025-12-31$14.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure35.1Shareholders' equity, Q3 FY2026, at 2026-03-31$35.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure35.3Shareholders' equity, FY2026, at 2026-06-30$35.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure

Cash flow

Operating cash flow$4.4m, Q4 FY2026
Capital expenditure$12.0k, Q4 FY2026
Aytu Biopharma, Inc, cash flow, quarterly
Line itemUnitQ1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Operating cash flow$k(211)Operating cash flow, Q1 FY2024, three months to 2023-09-30−$211.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2023-11-14, accession 0001558370-23-019015.Report this figure(135)Operating cash flow, Q2 FY2024, three months to 2023-12-31−$135.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-12, accession 0001437749-25-003568. Derived: 6-month figure less the 3-month figure.Report this figure(254)Operating cash flow, Q3 FY2024, three months to 2024-03-31−$254.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001437749-25-016833. Derived: 9-month figure less the 6-month figure.Report this figure(788)Operating cash flow, Q4 FY2024, three months to 2024-06-30−$788.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-09-23, accession 0001437749-25-029723. Derived: 12-month figure less the 9-month figure.Report this figure(1,190)Operating cash flow, Q1 FY2025, three months to 2024-09-30−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure2,905Operating cash flow, Q2 FY2025, three months to 2024-12-31$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-03, accession 0001437749-26-002804. Derived: 6-month figure less the 3-month figure.Report this figure(6,455)Operating cash flow, Q3 FY2025, three months to 2025-03-31−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001437749-26-016721. Derived: 9-month figure less the 6-month figure.Report this figure2,803Operating cash flow, Q4 FY2025, three months to 2025-06-30$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure(618)Operating cash flow, Q1 FY2026, three months to 2025-09-30−$618.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure3,675Operating cash flow, Q2 FY2026, three months to 2025-12-31$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-03, accession 0001437749-26-002804. Derived: 6-month figure less the 3-month figure.Report this figure(4,182)Operating cash flow, Q3 FY2026, three months to 2026-03-31−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001437749-26-016721. Derived: 9-month figure less the 6-month figure.Report this figure4,406Operating cash flow, Q4 FY2026, three months to 2026-06-30$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure
Capital expenditure$knot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-05-14, accession 0001437749-25-016833. Derived: 9-month figure less the 6-month figure.Report this figure329Capital expenditure, Q4 FY2024, three months to 2024-06-30$329.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-09-23, accession 0001437749-25-029723. Derived: 12-month figure less the 9-month figure.Report this figure136Capital expenditure, Q1 FY2025, three months to 2024-09-30$136.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure6.0Capital expenditure, Q2 FY2025, three months to 2024-12-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-03, accession 0001437749-26-002804. Derived: 6-month figure less the 3-month figure.Report this figure69.0Capital expenditure, Q3 FY2025, three months to 2025-03-31$69.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001437749-26-016721. Derived: 9-month figure less the 6-month figure.Report this figure17.0Capital expenditure, Q4 FY2025, three months to 2025-06-30$17.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure17.0Capital expenditure, Q2 FY2026, three months to 2025-12-31$17.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-03, accession 0001437749-26-002804. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001437749-26-016721. Derived: 9-month figure less the 6-month figure.Report this figure12.0Capital expenditure, Q4 FY2026, three months to 2026-06-30$12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-22, accession 0001437749-26-030908. Derived: 12-month figure less the 9-month figure.Report this figure

Shares

Diluted shares (weighted)10.51m, Q3 FY2026
Aytu Biopharma, Inc, shares, quarterly
Line itemUnitQ1 FY20232022-09-30Q2 FY20232022-12-31Q3 FY20232023-03-31Q1 FY20242023-09-30Q2 FY20242023-12-31Q3 FY20242024-03-31Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31
Diluted shares (weighted)m shares2.5Diluted shares (weighted), Q1 FY2023, three months to 2022-09-302,517,906 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001558370-23-019015.Report this figure3.1Diluted shares (weighted), Q2 FY2023, three months to 2022-12-313,110,304 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-02-21, accession 0001558370-23-001645.Report this figure3.7Diluted shares (weighted), Q3 FY2023, three months to 2023-03-313,726,779 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-11, accession 0001558370-23-009367.Report this figure5.5Diluted shares (weighted), Q1 FY2024, three months to 2023-09-305,482,037 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001437749-24-034970.Report this figure5.5Diluted shares (weighted), Q2 FY2024, three months to 2023-12-315,517,670 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-12, accession 0001437749-25-003568.Report this figure5.5Diluted shares (weighted), Q3 FY2024, three months to 2024-03-315,533,555 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001437749-25-016833.Report this figure9.1Diluted shares (weighted), Q1 FY2025, three months to 2024-09-309,099,601 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure8.5Diluted shares (weighted), Q2 FY2025, three months to 2024-12-318,485,112 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure8.2Diluted shares (weighted), Q3 FY2025, three months to 2025-03-318,204,453 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure19.5Diluted shares (weighted), Q1 FY2026, three months to 2025-09-3019,476,635 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001437749-25-034825.Report this figure10.0Diluted shares (weighted), Q2 FY2026, three months to 2025-12-3110,036,359 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-03, accession 0001437749-26-002804.Report this figure10.5Diluted shares (weighted), Q3 FY2026, three months to 2026-03-3110,511,583 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001437749-26-016721.Report this figure

Shares outstanding: 10.87mShares outstanding, period not labelled, at 2026-09-1510,866,708 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2026-09-22, accession 0001437749-26-030908.Report this figure at Sep 15, 2026, from the cover of the 10-K filed Sep 22, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.